razoxane has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agee, S; Estis, J; Hasinoff, B; Herman, EH; Knapton, A; Lipshultz, S; Lu, QA; Rosen, E; Rosenzweig, B; Thompson, K; Todd, JA; Zhang, J | 1 |
| Gu, Y; Li, K; Zhang, J; Zhou, Y | 1 |
2 other study(ies) available for razoxane and imatinib mesylate
| Article | Year |
|---|---|
A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat.
Topics: Animals; Apoptosis; Autophagy; Benzamides; Cardiotoxins; Heart Diseases; Imatinib Mesylate; Lysosomal-Associated Membrane Protein 2; Male; Muscle Cells; Myocardium; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Piperazines; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Razoxane; Sarcomeres; Troponin; Weight Gain | 2011 |
Chronic myeloid leukaemia in a patient with psoriasis following bimolane treatment.
Topics: Antineoplastic Agents; Dermatologic Agents; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Psoriasis; Razoxane | 2020 |